Publication | Open Access
Targeting m <sup>6</sup> A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
241
Citations
23
References
2023
Year
YTHDF1 impairs antitumour immunity via an m<sup>6</sup>A-p65-CXCL1/CXCR2 axis to promote CRC and serves as a therapeutic target in immune checkpoint blockade therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1